# This Study is a Prospective, Multi-center, Real World, Observational Study, Which Aims at Evaluating Intermediate and Long-term Efficacy of Endovascular Treatment for TASC C&D Aortoiliac Occlusive Disease.

> **NCT05391815** · — · RECRUITING · sponsor: **Shanghai Zhongshan Hospital** · enrollment: 800 (estimated)

## Conditions studied

- Peripheral Arterial Disease

## Interventions

_None listed._

## Key facts

- **NCT ID:** NCT05391815
- **Lead sponsor:** Shanghai Zhongshan Hospital
- **Sponsor class:** OTHER
- **Phase:** —
- **Study type:** OBSERVATIONAL
- **Status:** RECRUITING
- **Start date:** 2021-04-01
- **Primary completion:** 2027-06-01
- **Final completion:** 2032-06-01
- **Target enrollment:** 800 (ESTIMATED)
- **Last updated:** 2022-05-26

## Collaborators

- [object Object]
- [object Object]
- [object Object]
- [object Object]
- [object Object]
- [object Object]
- [object Object]
- [object Object]
- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT05391815

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT05391815, "This Study is a Prospective, Multi-center, Real World, Observational Study, Which Aims at Evaluating Intermediate and Long-term Efficacy of Endovascular Treatment for TASC C&D Aortoiliac Occlusive Disease.". Retrieved via AI Analytics 2026-05-27 from https://api.ai-analytics.org/clinical/NCT05391815. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*